Mediclinic International plc announced that on 25 May 2021, Messrs Alan Grieve and Trevor Petersen, both independent non-executive directors, informed the Board of their intention to retire as directors of the Company upon the conclusion of their second three-year term of appointment on 14 February 2022. In addition, with effect from 13 September 2021: Felicity Harvey will succeed Mr. Grieve as Senior Independent Director of the Company, Mr. Tom Singer will succeed Mr. Grieve as Chair of the Audit & Risk Committee, and Mr. Steve Weiner will succeed Mr. Petersen as Chair of the Remuneration Committee. Messrs Grieve and Petersen will step down from all Board committees with effect from 13 September 2021.